Fungal infections in ICU patients: Epidemiology and the role of diagnostics

Minerva Anestesiologica

Volumn 76, Issue 11, 2010, Pages 950-956

  Morace, G ^a   Borghi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Diagnosis; Intensive care units; Mycoses

Indexed keywords

AMPHOTERICIN B; ECHINOCANDIN; FLUCONAZOLE; TRIAZOLE DERIVATIVE;

ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; ARTICLE; ASPERGILLUS FUMIGATUS; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDEMIA; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG RESPONSE; ENZYME IMMUNOASSAY; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; MEDICAL INSTRUMENTATION; MORBIDITY; MORTALITY; MYCOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE; SYSTEMIC MYCOSIS; VALIDITY;

CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; MYCOSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78649455252     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 2009;69(Suppl 1):5-14.
2. Vincent J-L, Rello J, Marshal J, Silva E, Anzueto A, Martin CD et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
3. Opal SM, Calandra T. Antibiotic usage and resistance. Gaining or losing ground on infections in critically ill patients?. JAMA 2009;302:2367-8.
4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
5. Meersserman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;70:621-5.
6. Meersserman W, van Wijngaerden E. Invasive aspergillosis in the ICU:an emerging disease. Intensive Care Med 2007;33:1679-81.
7. Anaissie EJ,McGinnis MR, Pfaller MA. Clinical mycology. Philadelphia (PA): Churchill Livingstone; 2003
8. Larone DH. Medically important fungi:a guide to identification. 4th edition. Washington, DC:American Society for Microbiology Press; 2002.
9. Bendinelli M, Chezzi C, Dettori G, Manca N, Morace G, Polonelli L et al. Microbiologia medica, gli agenti infettivi dell'uomo:biologia, azione patogena, laboratorio: Micologia. Bologna: Monduzzi Editore; 2005.
10. Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2001;7;139:519-31.
11. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species:analysis of patients and review of the literature.Diagn. Microbiol. Infect. Dis 2007;59:401-6.
12. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis:a persistent public health problem. Clin Rev Microbiol 2007;20:133-63.
13. Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M et al. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 2009;64:625-9.
14. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O et al. Epidemiology of candidaemia in Europe:Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317-22.
15. Bouza E, Munoz P. Epidemiology of candidemia in intensive care units. Intn J. Antimicrob Agents 2008;32 (Suppl 2):S87-S91.
16. Marriott DJE, Playford EG, Chen S, Slavin M, Nguyen Q, Ellis D et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Critical Care 2009, 13:R115 [Internet] Available from: http://ccforum.com/content/13/4/R115 [cited 2010, Oct 18].
17. Singhi S, Deep A. Invasive candidiasis in pediatric intensive care units. Ind J Ped 2009;76:1033-44.
18. Dimopoulos G, Velegraki A, Falagas ME. A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrb Agents Chemother 2009;53:1242-4.
19. Vardakas KZ, Michapoulos A, Kiriakidou KG, Siampli EP, Samonis G, Falagas ME. Candidaemia:incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients Clin Microbiol Infect 2009;15:289-92.
20. Swaroop Vege S, Gardner TB, Chari ST, Baron TH, Clain JE, Pearson RK et al. Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis. Am J Gastroenterol 2009;104:2065-70.
21. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts-Third Informational Supplement, M27-S3. CLSI, Wayne, PA, USA; 2008.
22. Herbrecht R, Flückiger U, Gachot B, Ribaud P, Thiebaut A, Cordonnier C. Antifungal therapy in leukaemia patients:2009 update of the ECIL 1 and ECIL 2 guidelines. ECIL-3 Sept 25-26 2009, Juan-les-Pins, France [Internet]. Available from http://www.ebmt.org/5WorkingParties/IDWP/ECIL%203%20Antifungal%20therapy%20Update%202009.pdf [cited 2010, Oct 18].
23. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr et al. Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
24. De Rosa FG, Garazzino S, Pasero D, Di Perri G, Ranieri VM. Invasive candidiasis and candide mia:new guidelines. Minerva Anestesiol 2009;75:453-8.
25. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
26. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes ARJ, Groeneveld ABJ. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients Intensive Care Med 2007;33:1694-703.
27. Montagna MT, Iatta R, Borghi E, Morace G. The role of the laboratory in the diagnosis of invasive candidiasis. Drugs 2009;69(Suppl 1):59-63.
28. Shea YR. Algorithms for detection and identification of fungi. In: Murray PR, editor. Manual of clinical microbiology. 9th edition. Washington, DC:American Society for Microbiology Press, 2007:1745-61.
29. Hazen KC, Howell SA. Candida, Cryptococcus and other yeasts of medical importance. In:Murray PR, editor. Manual of clinical microbiology. 9th ed. Washington, DC:American Society for Microbiology Press, 2007:1762-88.
30. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005;49:3640-5.
31. Wheat LJ. Non culture diagnostic methods for invasive fungal infections. Curr Infect Dis Rep 2007;9:465-71.
32. Presterl E, Parschalk B, Bauer E, Lassnig A, Hajdu S, Graninger W. Invasive fungal infections and (1,3)-β-D-glucan serum concentrations in long-term intensive care patients. Intn J Infect Dis 2009;13:707-12.
33. Thomton CR. Detection of invasive aspergillosis. Adv Appl Microbiol 2010;70:187-216.
34. Meersseman W, Lagrou K, Maertens J, Wilmer A, Herman SG, Vanderschueren S et al. Galactomannan in bronchoalveolar lavage fluid:a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008;177:27-34.
35. White PL, Perry MD, Barnes RA. An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 2009;296:1-10.
36. Mancini N, Clerici D, Diotti R, Perotti M, Ghidoli N, De Marco D et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008;57:601-4.
37. Dierkes C, Ehrenstein B, Siebig S, Linde HJ, Reischl U, Salzberger B. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9:126.
38. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009;15:544-51.
39. Von Lilienfeld-Toal M, Lehmann LE, Raadts AD, Hahn-Ast C, Orlopp KS, Marklein G et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009;47:2405-10.
40. Varani S, Stanzani M, Paolucci M, Melchionda F, Castellani G, Nardi L et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 2009;58:346-51.
41. Avolio M, Diamante P, Zamparo S, Modolo ML, Grosso S, Zigante P et al. Molecular identification of bloodstream pathogens in patients presenting to the emergency room with suspected sepsis. Shock 2010;34:27-30.
42. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent J-L. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010;60:425-30.